Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)
Clinical trial NCT05172193 · UNKNOWN
Trial details
- NCT number
- NCT05172193
- Sponsor
- PT. Kimia Farma (Persero) Tbk
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-31
- Primary completion
- 2023-09-30
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.